Creative Medical Technology Holdings, Inc. Unrealized Gain (Loss) on Investments
Creative Medical Technology Holdings, Inc. (CELZ) reported Unrealized Gain (Loss) on Investments of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2025-03-14
- Creative Medical Technology Holdings, Inc. unrealized gain (loss) on investments for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Creative Medical Technology Holdings, Inc. unrealized gain (loss) on investments for fiscal 2023 was $34.09K.
| Period end | Unrealized Gain (Loss) on Investments 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-14 |
| 2023-12-31 | $34.09K 10-K · filed 2025-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |